Recent Articles from Investor Brand Network

A measure now moving through Pennsylvania’s State House could make cannabis available in stores overseen by the state. On Monday, House Democrats narrowly approved the measure in the Health Committee with a 14-12 vote.

Aegis Capital is pleased to announce its role as the sole book-running manager in the recently completed underwritten public offering for Super League Enterprise, Inc. (NASDAQ: SLE). The offering comprised 5,117,647 shares of common stock at a public offering price of $0.17 per share, resulting in gross proceeds of approximately $869,999 before underwriting fees and expenses. The company also granted Aegis a 45-day overallotment option to purchase up to an additional 767,647 shares, which could increase total gross proceeds to $1 million if fully exercised.

Cannabis Means Business (“CMB”), the industry’s premier business-to-business conference and expo, today shared new details on its schedule of panels and presentations, as well as programming, exhibitions and networking opportunities. The expo will feature a lineup of engaging speakers, including CNBC Fast Money trader Tim Seymour, Philip Wolf, a pioneer of the cannabis hospitality sector. and Dr. Chanda Macias, CEO of Women Grow.

IBN (InvestorBrandNetwork), a multifaceted communications organization committed to connecting companies with the investment community through its dynamic portfolio of 60+ brands, today announced its engagement as the official media partner for DealFlow Events’ inaugural DealFlow Discovery Day on Nuclear Energy . The event is slated to take place on May 22, 2025, at the conveniently located Jay Suites in New York City.

It is very natural to feel immense anxiety and fear after receiving a breast cancer diagnosis. Most people don’t consider seeking second opinions and would rather begin treatment right away. After all, breast cancer is one of the deadliest types of cancer in women, second only to lung cancer in terms of fatalities. The Breast Cancer Research Foundation estimates that slightly over 42,000 women will die from the condition in 2025, making it one of the most prolific killers in the USA.

The year 2024 was a big one for solar power. All around the world, countries worked hard to add new solar energy systems. By the end of the year, nearly 600 gigawatts (GW) of new solar power had been installed. This was a record-breaking number and showed how fast the world is turning to clean energy.

SolarBank (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2), a premier developer and owner of renewable and clean energy projects, specializing in distributed and community solar initiatives throughout Canada and the U.S., has announced a US$100 million project-based financing with infrastructure investor CIM Group to fund a 97 MW portfolio of solar energy projects in the United States. The deal marks a significant step in SolarBank’s evolution from solar developer to long-term asset owner, offering equity-style exposure to U.S. renewable energy growth without issuing new shares ( https://ibn.fm/J7XIZ ).

Nightfood Holdings (OTCQB: NGTF) announced the signing of a Letter of Intent to acquire the 120-room Hilton Garden Inn in Rancho Mirage, California for $36.93 million, marking one of the company’s largest deals to date. The hotel, adjacent to Disney’s Cotino(TM) residential resort community, will serve as a flagship site for Nightfood’s AI-powered Robotics-as-a-Service (“RaaS”) platform, which aims to reduce labor costs and enhance operational efficiency. The acquisition includes plans for a five-room expansion, a $3 million earn-out, and $26.43 million in Series C Preferred Stock, contingent on financial audits, mortgage conditions, and uplisting to a national exchange.

NRx Pharmaceuticals (NASDAQ: NRXP) announced it will release its first quarter 2025 financial results after market close on Thursday, May 15, 2025. The company will host a conference call at 4:30 p.m. ET the same day to discuss the results and provide a corporate update.

IBN, is pleased to announce the latest CryptoCurrencyWire audio production featuring Andrew Gordon, Managing Attorney of Gordon Law Group, a firm that focuses on helping individuals and businesses navigate the intricate world of digital asset taxation, including NFTs and DeFi. In the interview, Gordon outlines key steps for maintaining tax compliance in the crypto space, stressing that investors using multiple exchanges must take responsibility for gathering and organizing all relevant records. He notes that recordkeeping is a basic but crucial element of compliance, especially in a space where standardization across platforms is lacking.

Platinum Group Metals (NYSE American: PLG) (TSX: PTM) announced plans to raise approximately $1.01 million through a private placement of 800,000 common shares at $1.26 per share to major shareholder Hosken Consolidated Investments Limited (“HCI”), pending regulatory approval. The proceeds will support the company’s share of pre-construction activities at the Waterberg Project in South Africa and general corporate needs. The placement price reflects a 3.1% premium to the five-day VWAP on NYSE American as of May 9. Upon completion, HCI will return to a 26% ownership stake. The shares will be subject to a four-month-plus-one-day resale restriction and were offered under exemptions to registration and shareholder approval requirements due to HCI’s related-party status.

Oragenics (NYSE American: OGEN) will host a management update webinar on Tuesday, May 20, 2025, at 4:00 p.m. ET to discuss the unmet medical need in concussion treatment and highlight its lead candidate, ONP-002. The intranasal therapy is currently in a Phase IIa trial for mild traumatic brain injury and has shown promising preclinical results in reducing brain inflammation and swelling. Presenters will include CEO Janet Huffman, CMO Dr. James Kelly, and Chief Clinical Officer Dr. Frank Peacock, a national emergency medicine expert.

NUBURU (NYSE American: BURU) has received a Notice of Noncompliance from NYSE Regulation for failing to meet the $2 million stockholders’ equity requirement under Section 1003(a)(i) of the NYSE American Company Guide, following continued operating losses and a going concern warning in its latest 10-K. The notice does not immediately impact BURU’s trading status, though its ticker now carries a “.BC” designation. The company has until May 29 to submit a plan to regain compliance and until Oct. 29, 2026 to meet the listing standards. Management cited recent strategic initiatives as potential paths to compliance, though their success is not guaranteed.

Copper inventories on the SHFE (Shanghai Futures Exchange) are forecast to further reduce at the end of this week. The quick drop in supplies is expected to trigger a rise in prices, which could incentivize traders to resume shipping the metal to China.

Ucore Rare Metals (TSX.V: UCU) (OTCQX: UURAF) is a critical metals (“CM”) separation technology company executing an ESG-centered plan toward establishing a comprehensive North American critical metals supply chain. The company has developed a transformative commercial-ready technology, RapidSX(TM), for separating and purifying critical metals. Ucore intends to deploy this technology in pursuit of a CM supply chain independent of China for Western original equipment manufacturers (“OEMs”), most notably in the automotive and renewable energy industries.

Quantum BioPharma (NASDAQ: QNTM) announced the completion of dosing in 90-day oral toxicity and toxicokinetic studies for its lead candidate Lucid-21-302 (“Lucid-MS”), a novel treatment in development for multiple sclerosis. The results of these studies will support an Investigational New Drug (IND) application to the U.S. FDA, expected by year-end. Executives highlighted the milestone as a major step toward launching a Phase 2 clinical trial and positioning Lucid-21-302 as a first-in-class therapy for MS.

Wheaton Precious Metals (NYSE: WPM) (TSX: WPM) delivered record quarterly revenue of $470 million in Q1 2025, up 58.5% year over year, driven by a 36% increase in average realized gold equivalent prices and a 16% rise in GEOs sold. Adjusted net earnings rose 53% to $250.8 million, with operating cash flow climbing 64.5% to $361 million. The company declared a 6.5% dividend increase to $0.165 per share and highlighted its robust growth outlook, with four development projects expected to begin production in 2025. Wheaton ended the quarter with $1.1 billion in cash and no debt, supporting its ongoing expansion strategy and capital commitments.

New research shows that using cannabis while pregnant can put both the mother and baby at serious risk. A large-scale review of past studies found links between prenatal cannabis use and problems like low birth weight, premature birth, and even infant death.

Platinum Group Metals (NYSE American: PLG) (TSX: PTM) is advancing the development of its Waterberg Project in South Africa, a large-scale platinum group metals (“PGM”) mine expected to be among the world’s largest and lowest-cost underground operations. In September 2024, an independent definitive feasibility study (“DFS”) was completed for Waterberg, highlighting its robust economics, including projected steady state annual production of 353,208 ounces of platinum, palladium, rhodium and gold, along with significant copper and nickel by-products, over a 54-year mine life. Located in the Bushveld Complex, the project features thick, shallow ore bodies allowing for safer, more efficient mining. Amid rising global demand for PGMs—especially in automotive, electronics, and clean energy sectors—Platinum Group Metals is strategically positioned to meet future market needs.

Calidi Biotherapeutics (NYSE American: CLDI) recently announced promising preclinical results for its innovative RTNova platform, which has successfully delivered transient gene-therapy payloads to targeted tumors. In addition, Calidi’s virotherapy demonstrated efficacy in killing more than 60 different tumor cell lines, showcasing the platform’s potential to revolutionize cancer treatment by enabling both tumor destruction and robust immune activation.

DealFlow Events today announced the launch of the inaugural DealFlow Discovery Day on Nuclear Energy, slated to take place in New York City on May 22, 2025. The event provides a forum for discovering new investment opportunities and exchanging ideas with industry stakeholders including utilities, financiers, site developers, technology providers, and government entities. Especially timely in light of the renaissance in the nuclear energy sector on the back of strong demand for clean energy and the intensive operations of data centers and AI technologies, the event will feature an insights-packed agenda. Thought leaders and top management of companies in the sector will share first-hand perspectives on a variety of pertinent industry topics, including business models, sectoral opportunities and challenges, and avenues of future expansion. The platform provides a unique opportunity for CEOs and senior leadership teams to showcase their companies to professional investors.

NUBURU (NYSE American: BURU) has announced the formation of a strategic working group to revitalize its Blue-Laser Business Unit, aiming to strengthen its position in the defense sector. The move follows a Joint-Pursuit Agreement with a defense-tech partner and plans to introduce vertical applications that enable cross-selling to existing and new clients. NUBURU is also advancing discussions to bring in a senior revenue and marketing strategist, while leveraging AI-driven insights from NexGenAI Solutions Group. The initiative includes the development of a new state-of-the-art operational facility to support this next phase of growth.

Knightscope (NASDAQ: KSCP) has joined the Association for Uncrewed Vehicle Systems International (“AUVSI”), reinforcing its commitment to autonomous security innovation and federal policy leadership. The company will participate in AUVSI’s Cyber, Ground, and Defense Advocacy Committees, including a new Robotics Subcommittee focused on shaping a National Robotics Strategy. Knightscope plans to contribute its expertise in autonomous ground robotics and AI-driven public safety systems to help guide U.S. standards and legislation for uncrewed technologies.

D-Wave Quantum Inc. (NYSE: QBTS) (“D-Wave”), a leader in quantum computing systems, software, and services, posted record first quarter 2025 revenue of $15 million, up 509% from the prior year. Business and financial results for the quarter included the first Advantage annealing quantum computer sale and publication of breakthrough research demonstrating quantum supremacy on a real-world problem.

Last week saw the price of gold hit $3,400 per troy ounce as the dollar saw its value diminish, driven by growing concerns over geopolitical tensions and shifting global trade dynamics. Despite the closure of the London Bullion Market and Shanghai Gold Exchange for May Day celebrations, the rally in gold prices continued worldwide, reflecting increased investor demand for safe haven assets.

For many years, global human development showed consistent progress, and experts from the United Nations had once forecasted that by 2030, people worldwide would experience substantial improvements in their quality of life. However, recent events have changed that outlook. A series of major disruptions—most notably the COVID-19 pandemic—have caused setbacks in development across all parts of the world.

Medulloblastoma is a commonly occurring pediatric brain cancer in kids and adolescents. The cancer develops within the cerebellum, the part of the brain responsible for coordinating movement and other functions. These tumors enlarge quickly, can grow into nearby tissues, and in some cases, can metastasize. The variations in these tumors make it challenging to find appropriate treatments.

German automaker Audi registered a notable increase in vehicle sales in the first quarter of the year, thanks to the growing popularity of its battery electric vehicle (BEV) models. The carmaker’s Q1 2025 earnings report showed revenue of $16.6 billion, a 12.4% increase from Audi’s reported revenue in Q1 2024.

Standard Lithium (NYSE American: SLI) reported Q1 2025 results and highlighted major progress on its flagship Southwest Arkansas Project, including finalizing a $225 million U.S. Department of Energy grant and securing unanimous approval for its first brine production unit. The project was also designated a priority under Executive Order 14241 to boost American mineral production. In partnership with Equinor under the newly branded Smackover Lithium joint venture, the company completed final field-pilot testing with over 99% lithium recovery. With $31.6 million in cash and no debt, the company remains on track for further permitting and royalty approvals in Q2.

Wheaton Precious Metals (NYSE: WPM) (TSX: WPM) has declared its second quarterly cash dividend of 2025 at $0.165 per common share, marking a 6.5% increase over the same quarter last year. The dividend will be paid on or about June 10 to shareholders of record as of May 28, with the ex-dividend date also set for May 28. The company’s Dividend Reinvestment Plan (“DRIP”) remains active, with shares issued through treasury at market price and no discount applied for this quarter.

SolarBank (NASDAQ: SUUN) (CSE: SUNN) has filed a final short form base shelf prospectus with Canadian securities regulators, replacing its previous version set to expire in June 2025. The new Shelf Prospectus allows the company to offer up to C$200 million in securities—including common shares, debt instruments, warrants, and units—over the next 25 months. A corresponding Form F-10 registration has been filed with the U.S. SEC but is not yet effective. Proceeds from any future offerings will support business development, working capital, debt repayment, capital programs, and potential

The opioid crisis remains a critical public health challenge in the U.S. and globally, prompting a series of new regulatory measures designed to improve safety and reduce misuse. In early 2025, the FDA approved Journavx (suzetrigine), a first-in-class non-opioid painkiller offering patients safer alternatives to opioids. Additionally, opioid manufacturers are now required to include prepaid mail-back envelopes for safe disposal of unused medications, while enhanced boxed warnings on opioid labels further reinforce the dangers of misuse, addiction, and overdose.

McEwen Mining (NYSE: MUX) (TSX: MUX) reported Q1 2025 results and outlined growth plans at its Fox Complex, targeting 60,000 ounces of annual gold production by 2027 and a potential expansion to 150,000 ounces by 2030, pending permits. Total annual output could rise to 225,000–255,000 gold equivalent ounces. Backing this plan, the company completed a $110 million convertible note financing. Q1 consolidated production totaled 24,131 GEOs, with improvements expected throughout the year to meet 2025 guidance of 120,000–140,000 GEOs. Gross profit rose to $10.1 million from $6.0 million in Q1 2024, driven by a 31% increase in average realized gold prices. Net loss narrowed to $3.9 million from $20.4 million a year ago. McEwen also confirmed progress at Gold Bar, San José and Grey Fox, and expects to publish a feasibility study on the Los Azules copper project in July.

A survey commissioned by the Secure Energy Project and conducted by research agency Opinium has revealed that most Europeans would rather their countries invest in local clean energy rather than continue importing fossil fuels from the U.S. and Russia. The poll found that Europeans overwhelmingly prefer relying on domestically produced renewable energy, a more reliable and sustainable option, over fossil fuels sourced from abroad.

Venture capital investment in the crypto sector is declining, both in terms of the amount raised and the frequency of deals. The latest data from April shows that instead of a wide spread of smaller investments, there are fewer but much larger funding rounds.

Ford Motor Company has started 2025 on a stronger note, showing signs of progress in its electric vehicle (EV) business. In the first quarter, the company’s Model e division, which focuses on electric cars, recorded a big jump in sales and a smaller financial loss compared to last year.

A recent Canadian study focused on marijuana use among young adults offers insights into which behaviors and personal characteristics are linked to higher risks of marijuana-related problems.

Adageis, a healthcare technology company, is transforming how providers manage insurance payments with its AI-driven software platform, designed to enhance transparency, ensure reimbursement, and support the shift to value-based care. By offering real-time insights into expected payments, identifying reimbursement gaps, and evaluating performance, Adageis empowers clinics—especially smaller or new practices—to optimize revenue, negotiate better insurance contracts, and make informed financial decisions. The platform helps providers navigate complex insurance arrangements while improving profitability, quality, and a focus on patient care. With growing interest in the healthcare technology sector, Adageis stands out as a promising investment opportunity.

Nightfood Holdings (OTCQB: NGTF) is rapidly expanding its footprint in the hospitality and hotel automation sectors through strategic acquisitions, signaling its strong momentum and long-term vision. The company recently closed deals for CarryoutSupplies.com and Skytech Automated Solutions Inc., combining industry leading packaging capabilities with advanced automation technology to enable scalable, efficient solutions. In addition, Nightfood signed a letter of intent to acquire the assets of Victorville Treasure Holdings LLC, owner and operator of a 155-room Holiday Inn(R) in Victorville, California, which is being renovated for rebranding under Courtyard by Marriott(R). With over 130 hotels under management and a growing ecosystem that includes robotic service technology, Nightfood is positioning at the forefront of the hospitality industry’s evolution—aiming to address labor shortages, enhance efficiency, and lead a new era of hospitality and hotel management innovation.

Nicola Mining (TSXV: NIM) (FSE: HLIA) (OTCQB: HUSIF) a junior exploration company with near-term cash flow and district-scale copper potential, has been initiated with an Outperform rating and a price target of C$0.70 (US$0.50) . The coverage highlights Nicola’s diversified asset base, including its flagship New Craigmont Copper Project, the high-grade Treasure Mountain silver-lead-zinc mine, and a 75% economic interest in the Dominion Creek gold project.

D-Wave Quantum Inc. (NYSE: QBTS) (“D-Wave”), a leader in quantum computing systems, software, and services, announced that it will participate in several upcoming investor conferences. These include the Needham Technology, Media & Consumer Virtual Conference on May 9 and 12, the J.P. Morgan Global TMC Conference on May 13 in Boston, the J.P. Morgan Virtual Quantum Conference on May 20, the B. Riley Institutional Investor Conference on May 21 in Los Angeles, the Stifel 2025 Boston Cross Sector Conference on June 3-4, and the ROTH London Conference on June 24-26.

Newton Golf Company (NASDAQ: NWTG) Motion shafts are garnering significant attention for the impressive performance benefits they offer, particularly among players on the Champions Tour. A recent Golf.com article praised the high-quality construction of these shafts and noted that a growing number of golfers competing at the highest levels of senior professional golf are making the switch to Newton’s innovative equipment ( https://ibn.fm/jj5ki ). This surge in popularity highlights Newton Golf’s commitment to pushing the boundaries of golf shaft technology, offering players a more consistent, powerful and reliable swing.

Sekur Private Data (CSE: SKUR) (OTCQB: SWISF) (FSE: GDT0) has initiated a marketing campaign targeting up to 1 million U.S. consumers affected by email data breaches, including a recent incident impacting 1.8 billion Gmail users. The Swiss-hosted cybersecurity company plans to extend its outreach to over 5 million businesses across financial, legal, and real estate sectors. Sekur’s secure communications suite includes encrypted email, messaging, and VPN services, with enterprise features coming soon. The company is positioned in a $14.5 billion market for secure mobile communications projected to reach $88.8 billion by 2032.

TransCode Therapeutics (NASDAQ: RNAZ) announced that the third patient in Cohort 4 of its Phase 1a trial for RNA-based cancer therapeutic TTX-MC138 has been dosed, with 15 patients now treated across four dose levels. The Safety Review Committee approved expanded enrollment and noted no significant toxicities or disease progression to date. Ten patients remain on study, with the longest treated showing stable disease after seven cycles. Early PK/PD data confirm target engagement and support advancing to the Phase 1b dose expansion stage.

A recent report from Bloomberg has made a strong case for allowing Chinese vehicles into the American market. China has made significant strides in the auto sector over the past couple of decades, growing from a country that was almost fully reliant on imported vehicles to one that now dominates the globe in vehicle sales.

New research suggests that a simple examination of the retina could provide an early diagnosis of Parkinson’s disease. Universite Laval researchers conducted this study and their findings appeared in the Neurobiology of Disease journal.

The start of this week saw prices for gold futures increase as safe haven demand by investors, particularly from China, grows. The price of silver also increased, with a weaker dollar index favoring the precious metals markets. May silver prices rose to $32.37 while June gold prices hit $3324.60.

AI is already transforming how we work, and many jobs will eventually be automated . But instead of resisting change or clinging to old methods, it’s time to shift focus. Competing with machines on speed or data processing is a losing battle. The real advantage lies in being more human, not more robotic.

Cybin (NYSE American: CYBN) (NEO: CYBN) a clinical-stage neuropsychiatry company, announced the issuance of U.S. patent 12,291,499 for its CYB003 program targeting major depressive disorder (MDD). The patent covers pharmaceutical compositions and oral dosage forms related to Cybin’s proprietary deuterated psilocin analog and offers exclusivity through 2041. The company is currently dosing patients in a Phase 3 trial and emphasized the importance of strong IP protection as it advances next-generation mental health therapies.

Clene (NASDAQ: CLNN) announced first quarter 2025 financial results and progress on its CNM-Au8 program for ALS and MS. The company is preparing for a potential NDA submission under the FDA’s Accelerated Approval pathway for ALS in Q4 2025, supported by survival data and upcoming biomarker analysis. New data also showed CNM-Au8 significantly improved survival in patients with more severe ALS. In MS, Clene presented Phase 2 extension results demonstrating remyelination and neuronal repair. The company reported a Q1 net loss of $0.8 million on reduced expenses and $9.8 million in cash, funding operations into Q3 2025.

SolarBank (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2), a premier developer and owner of renewable and clean energy projects, specializing in distributed and community solar initiatives throughout Canada and the U.S., announced the development of a new 7.2 megawatt DC ground-mount solar project in upstate New York. The Glor Rd project, as it is known, adds to a string of solar installations that the company is developing across the region ( https://ibn.fm/Z98Pf ).

NanoViricides, Inc. (NYSE American: NNVC) announced approval from the Democratic Republic of Congo’s National Ethics Committee for Health for its planned Phase II clinical trial of NV-387, a broad-spectrum antiviral targeting Mpox (hMPXV). The company is finalizing its Clinical Trial Application for submission to the Ministry of Public Health. NV-387, a host-mimetic antiviral, has shown strong preclinical results across multiple viruses including influenza, RSV, coronaviruses, and orthopoxviruses. NanoViricides sees the therapy as a potential breakthrough for treating viral diseases that evade existing drugs.

Energy Fuels (NYSE American: UUUU) (TSX: EFR) a top U.S. producer of uranium and rare earth elements, reported a net loss of $26.3 million for Q1 2025 on $16.9 million in revenue. Despite the loss, tied to inventory strategy and ramp-up costs, the company boosted its 2025 uranium production guidance to up to 1 million pounds, citing strong grades at the Pinyon Plain mine. Inventory grew to 1.3 million pounds of U₃O₈, while partnerships with Chemours and POSCO advanced Energy Fuels’ U.S.-based rare earth supply chain strategy. The company ended the quarter with over $210 million in working capital and no debt.

McEwen Mining (NYSE: MUX) (TSX: MUX) announced standout drill results from its Fox Complex’s Grey Fox Project, including what the company described as some of the best intercepts yet from the Gibson zone. Highlights include 12.4 g/t gold over 10.7 meters and 4.0 g/t over 30.1 meters, the latter potentially indicating a broad mineralized zone. Drilling at Grey Fox South extended mineralization 250 meters below the existing resource base, while a separate intercept at the 147 Zone returned 48.5 g/t gold over 0.8 meters. A new exploration corridor and promising results near the Whiskey Jack Zone further support resource growth at the site.

Alphabet (NASDAQ: GOOGL) (NASDAQ: GOOG) is one of several tech giants ramping up capital expenditures in 2025 to accelerate artificial intelligence development, reinforcing long-term demand for Nvidia’s AI chips. Alongside Meta, Amazon, and Microsoft, Alphabet is helping drive a projected $300 billion in collective tech infrastructure investment this year. The expanded AI budgets reflect a race to dominate next-gen digital experiences and data center capabilities. For Alphabet, the increased spend strengthens its AI-first approach, including continued development of its Gemini AI model and advanced cloud-based AI services.

Scinai Immunotherapeutics (NASDAQ: SCNI), a biopharma company focused on inflammation and immunology treatments and CDMO services, reported a $4.8 million net gain for 2024, reversing a $6.5 million loss in 2023. The improvement was largely due to $14.8 million in financial income from a loan-to-equity conversion. The company posted $658,000 in revenue—its first ever—from its CDMO unit. R&D expenses remained steady at $5.6 million, while G&A costs dropped to $2.6 million. Cash and equivalents totaled $1.9 million at year-end.

ESGold (CSE: ESAU) (OTCQB: ESAUF), a fully permitted, pre-production resource company on a clear path to near-term gold and silver production, has reported the identification of a significant geophysical anomaly in the southwest portion of its Montauban Project in Quebec. According to a company press release, internal analysis of historical VTEM ( Versatile Time Domain Electromagnetic ) survey data and drill records has highlighted this area as a high-priority exploration target ( https://ibn.fm/1esM9 ).

The Global Solar Council (GSC) is celebrating a decade of progress in the photovoltaic solar energy industry. The industrial body marked its 10th anniversary by encouraging investors and governments to increase their efforts to boost solar energy growth over the next decade. Solar is currently the largest source of renewable energy globally and is poised to play an instrumental role in the transition to clean energy.

The European Union (EU) is preparing to enforce strict new rules targeting money laundering, with major implications for cryptocurrencies. Starting in 2027, privacy-focused digital currencies and anonymous crypto accounts will no longer be allowed under the bloc’s updated anti-money laundering regulations.

ESGold (CSE: ESAU) (OTCQB: ESAUF), a pre-production gold and silver company advancing its fully permitted Montauban Project in Quebec, will present at the Metals Investor Forum in Vancouver on May 9, 2025. The company was invited by Silver Stock Investor author Peter Krauth, who recognized ESGold as a high-potential junior nearing production. ESGold’s presentation, scheduled for 2:50 p.m. PST at the Rosewood Hotel Georgia, will include updates on construction progress and upcoming gold-silver production expected by year-end.

Electric vehicles (EVs) are crucial for cutting pollution and fighting climate change. But as more drivers switch to EVs, a new challenge arises: What happens if everyone charges their cars at the same time? A recent study suggests a simple solution; small financial rewards could prevent power grid overloads and keep energy flowing smoothly.

Running advertisements in the cannabis industry isn’t as straightforward as it is for other sectors. Business owners face a maze of regulations that make promoting their products difficult. These rules are often seen as restrictions on free speech because they limit what companies can say about their products, even when the information is accurate and meant for adults.

Nicola Mining (TSX.V: NIM) (OTCQB: HUSIF), a junior resource company focused on monetizing high-grade mineral assets in British Columbia, is positioned for opportunity with a unique dual-pronged business model to generate revenue and long-term growth. It operates a fully owned, state-of-the-art gold and silver mill while also advancing exploration on 100%-owned copper, silver, and gold projects. This approach allows Nicola to fund ongoing development while minimizing equity dilution.

Match Group (NASDAQ: MTCH) continues to hold a “Moderate Buy” consensus rating from Wall Street analysts, even as the stock underperforms broader market indices. According to Barchart, 24 analysts currently cover the stock, with the consensus rating remaining steady at 3.71 out of 5 over the past three months. This suggests cautious optimism about the company’s long-term prospects, despite recent challenges. However, technical indicators present a more bearish outlook, with Barchart’s composite technical opinion rating the stock as a 72% “Sell,” indicating a weakening short-term trend.

Meta Platforms (NASDAQ: META) is considered undervalued following its recent earnings report, with Morningstar assigning a 4-star rating and maintaining a fair value estimate of $770 per share. The company’s strong performance, driven by robust advertising revenue and advancements in artificial intelligence, has led to increased confidence among analysts. Despite potential macroeconomic and regulatory challenges, Meta’s focus on AI and its core advertising business positions it well for long-term growth.

Alphabet (NASDAQ: GOOGL) (NASDAQ: GOOG) saw its stock decline following reports that Apple is in discussions to integrate OpenAI’s artificial intelligence technology into its Safari browser, a move that could challenge Google’s dominance in web search. Apple is reportedly exploring the incorporation of AI search features in the upcoming iOS 18, and while talks with Google continue regarding its Gemini AI, a potential shift to OpenAI’s technology could disrupt the long-standing partnership that currently makes Google the default search engine on Apple devices. Investors are reacting to the possibility that Apple may diversify or even reduce its reliance on Google’s search tools.

Tesla (NASDAQ: TSLA) is under scrutiny as Lehigh County, Pennsylvania’s pension board becomes the first known U.S. pension fund to halt new investments in the company. The board, overseeing $500 million in assets, voted 4-2 to cease purchasing Tesla stock, citing CEO Elon Musk’s political involvement and the company’s declining performance. The decision follows a 71% drop in Tesla’s earnings and a 20% decrease in automotive revenue. The board has also directed its investment manager to explore options for divesting existing passive holdings. This move aligns with broader national and international pressures, including calls from New York legislators and labor unions for divestment, as well as similar actions by major pension funds in the Netherlands and Denmark.

Apple (NASDAQ: AAPL) shares pulled back following news that the company reduced its share repurchase activity in the March quarter, triggering concern among short-term investors. While Apple still authorized a record $110 billion in future buybacks, the actual spending in the most recent quarter was lower than prior periods. Analysts argue that the stock reaction may be shortsighted, as the company continues to generate substantial cash flow and remains focused on long-term capital return strategies. The pullback also comes as Apple prepares to unveil new AI features and potentially reshape its search partnerships, further boosting its strategic positioning.

ESGold (CSE: ESAU) (OTCQB: ESAUF) a pre-production gold and silver company advancing its Montauban Project in Quebec, has issued 500,000 restricted share units (“RSUs”) to new board member Peter Espig as part of its equity incentive plan. Espig brings deep experience in project finance and transitioning juniors to producers. The company also confirmed that construction at its Montauban processing site is progressing on schedule, with the delivery of Humphrey Spirals—key to the gravity recovery circuit—expected next week. ESGold targets production by year-end 2025.

Newton Golf Company (NASDAQ: NWTG) Co-Founder and CTO Aki Yorihiro appeared on the latest episode of IBN’s TechMediaWire Podcast to discuss the company’s Fast Motion Shaft, now in use on the PGA TOUR Champions, LPGA, and Korn Ferry Tours. Yorihiro outlined how the shaft’s speed-optimized design and Newton’s proprietary fitting system are reshaping performance standards for players of all types. With over 30 tour pros already using Newton shafts, the company continues to push innovation in golf technology through science-backed engineering and user-centered design.

Foremost Clean Energy (NASDAQ: FMST) (CSE: FAT) announced the successful completion of a high-resolution airborne geophysical survey over its CLK Uranium Property in Saskatchewan’s Athabasca Basin. Conducted by Expert Geophysics Surveys Inc., the 771 line-kilometer MobileMT electromagnetic survey aims to map subsurface conductors linked to uranium mineralization. The results, expected in the coming weeks, will guide target selection for Foremost’s summer 2025 drill program. Historic drilling at CLK includes notable intercepts, such as 8,600 ppm U in hole CLG-D1, highlighting the property’s untapped discovery potential.

Intelligent Bio Solutions (NASDAQ: INBS) is a medical technology company pioneering rapid, non-invasive diagnostics through its proprietary Intelligent Fingerprinting Drug Screening System. By utilizing fingerprint sweat analysis, the company offers a cost-effective, hygienic solution to detect recent drug use — targeting substances commonly found in workplace settings such as opiates, cocaine, methamphetamine, and cannabis. This innovative approach positions INBS to transform drug testing protocols, particularly in industries where safety and speed are mission critical.

Gaxos.ai (NASDAQ: GXAI), a company focused on artificial intelligence applications, announced that its product, Gaxos Labs for Game Developers and Publishers, has been approved for listing on Amazon Web Services (AWS) Marketplace. This strategic milestone allows Gaxos Labs to be deployed by AWS users in over 245 countries, offering enterprise clients integrated billing, global scalability, and enhanced margin efficiency. CEO Vadim Mats stated the listing transforms Gaxos Labs into a cloud-native, enterprise-grade service that fits seamlessly into AWS-based game development workflows.

Emperor Metals (CSE: AUOZ) (OTCQB: EMAUF) (FRA:9NH) has engaged Norda Stelo to conduct a Gap Analysis Study for its Lac Pelletier Gold Project in Quebec, marking a critical step toward the potential launch of its exploitation phase. The mandate includes a full review of environmental permitting and identification of regulatory requirements ahead of mining activity. CEO John Florek noted that this milestone positions Emperor as a potential near-term cash-flow producer, with the project already featuring extensive underground development, a mining permit for 1,000 tons per day, and over 100,000 meters of historical drilling. Emperor aims to define a one-million-ounce resource in 2025, supported by rising gold prices and the site’s proximity to infrastructure and adjacent Agnico Eagle assets.

Telomir Pharmaceuticals (NASDAQ: TELO) has released new preclinical data showing its lead oral candidate, Telomir-1, reverses key markers of cellular decline in human cell lines, including improved mitochondrial activity, reduced oxidative stress, and restored calcium balance. The findings underpin Telomir’s expansion into autism spectrum disorder (ASD) and spasmodic dysphonia (SD), both of which share biological disruptions targeted by Telomir-1. The company also plans to engage with the FDA’s Rare Disease Endpoint Advancement Pilot Program to accelerate development in rare conditions like progeria and Wilson’s disease.